Trial Profile
A prospective study of lenalidomide in patients with multiple myeloma.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 27 Nov 2015
Price :
$35
*
At a glance
- Drugs Lenalidomide (Primary)
- Indications Multiple myeloma
- Focus Therapeutic Use
- 27 Nov 2015 New trial record